Sun Pharma challenges Abilify patent term extension

Intellectual Property 2024-03-22 9:01 am By Sam Matthews | Melbourne

Indian generics company Sun Pharma has taken Otsuka Pharmaceutical to court, alleging an extension for the patent for an injectable form of the Japanese drug maker’s blockbuster antipsychotic Abilify was wrongly granted and should be invalidated.